Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-18

Clinical Trial Update: Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports completion of a study evaluating the effects of rosiglitazone and metformin on metabolism in individuals with type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosiglitazone (rosiglitazone)
  • metformin (metformin)

Snippet

Sponsor: Turku University Hospital | Conditions: Insulin Sensitivity, Type 2 Diabetes | Phase 4 | Status: COMPLETED